Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

Publication Date: February 17, 2022

Last Updated: November 29, 2023

Summary of Recommendations

Isocitrate dehydrogenase (IDH) mutational testing must be performed on all diffuse gliomas (DG). (S)

1226065

Overview

Title

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

Summary of Recommendations

Overview

Title

Authoring Organizations